CDK4/6 inhibitors in the continuum of care for HR+ HER2- Breast Cancer
1. Recent updates about CDK4/6 inhibitors in the adjuvant setting
2. Strategies for side effect management and improving patient adherence when using CDK 4/6 inhibitors
FREE
Free